JPWO2023091606A5 - - Google Patents

Info

Publication number
JPWO2023091606A5
JPWO2023091606A5 JP2024529343A JP2024529343A JPWO2023091606A5 JP WO2023091606 A5 JPWO2023091606 A5 JP WO2023091606A5 JP 2024529343 A JP2024529343 A JP 2024529343A JP 2024529343 A JP2024529343 A JP 2024529343A JP WO2023091606 A5 JPWO2023091606 A5 JP WO2023091606A5
Authority
JP
Japan
Prior art keywords
alkyl
optionally substituted
halogen
compound
independently selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024529343A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024540485A (ja
JP2024540485A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/050313 external-priority patent/WO2023091606A1/en
Publication of JP2024540485A publication Critical patent/JP2024540485A/ja
Publication of JP2024540485A5 publication Critical patent/JP2024540485A5/ja
Publication of JPWO2023091606A5 publication Critical patent/JPWO2023091606A5/ja
Pending legal-status Critical Current

Links

JP2024529343A 2021-11-17 2022-11-17 ピリダジノン化合物およびその使用 Pending JP2024540485A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163280457P 2021-11-17 2021-11-17
US63/280,457 2021-11-17
PCT/US2022/050313 WO2023091606A1 (en) 2021-11-17 2022-11-17 Pyridazinone compounds and uses thereof

Publications (3)

Publication Number Publication Date
JP2024540485A JP2024540485A (ja) 2024-10-31
JP2024540485A5 JP2024540485A5 (https=) 2025-11-25
JPWO2023091606A5 true JPWO2023091606A5 (https=) 2025-11-25

Family

ID=84519449

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024529343A Pending JP2024540485A (ja) 2021-11-17 2022-11-17 ピリダジノン化合物およびその使用

Country Status (4)

Country Link
US (1) US20240336609A1 (https=)
EP (1) EP4433473A1 (https=)
JP (1) JP2024540485A (https=)
WO (1) WO2023091606A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3877376T3 (da) 2018-11-06 2023-10-02 Edgewise Therapeutics Inc Pyridazinonforbindelser og anvendelser deraf
CA3118908A1 (en) 2018-11-06 2020-05-14 Edgewise Therapeutics, Inc. Pyridazinone compounds and uses thereof
AU2019374812B2 (en) 2018-11-06 2025-03-06 Edgewise Therapeutics, Inc. Pyridazinone compounds and uses thereof
WO2021231565A1 (en) * 2020-05-13 2021-11-18 Edgewise Therapeutics, Inc. Pyridazinone compounds for the treatment of neuromuscular diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1087725C (zh) 1994-03-25 2002-07-17 同位素技术有限公司 用氘代方法增强药物效果
US6334997B1 (en) 1994-03-25 2002-01-01 Isotechnika, Inc. Method of using deuterated calcium channel blockers
DE102007025718A1 (de) * 2007-06-01 2008-12-04 Merck Patent Gmbh Pyridazinonderivate
DE102007032507A1 (de) * 2007-07-12 2009-04-02 Merck Patent Gmbh Pyridazinonderivate
TWI902102B (zh) * 2017-04-06 2025-10-21 美商富曼西公司 殺真菌之噁二唑
DK3877376T3 (da) * 2018-11-06 2023-10-02 Edgewise Therapeutics Inc Pyridazinonforbindelser og anvendelser deraf
CA3118908A1 (en) * 2018-11-06 2020-05-14 Edgewise Therapeutics, Inc. Pyridazinone compounds and uses thereof
WO2021231565A1 (en) * 2020-05-13 2021-11-18 Edgewise Therapeutics, Inc. Pyridazinone compounds for the treatment of neuromuscular diseases

Similar Documents

Publication Publication Date Title
JP2021534106A5 (https=)
HRP20231389T1 (hr) Spojevi piridazinona i njihove upotrebe
JPWO2023099623A5 (https=)
JP2022506687A5 (https=)
JPWO2023099592A5 (https=)
EP3653620B1 (en) New heteroaryl amide derivatives as selective inhibitors of histone deacetylases 1 and 2 (hdac1-2)
JP2016534134A5 (https=)
JP2004518723A5 (https=)
JP2022506685A5 (https=)
TW200524575A (en) Biaryl linked hydroxamates: preparation and pharmaceutical applications
JP2006513268A5 (ja) アンタゴニスト活性を有するベンゾアゾリルピペラジン誘導体
JP2018531963A5 (https=)
JP2021534108A5 (https=)
JP2021526017A5 (https=)
JP2017525699A5 (https=)
JP2008513439A5 (https=)
WO2016101885A1 (en) Necrosis inhibitors
JP2019527724A5 (https=)
RU2016120610A (ru) Производное сульфонамида и его применение в медицине
RU2008107733A (ru) Ингибиторы gsk-3
JPWO2020139988A5 (https=)
JPWO2021231565A5 (https=)
JPWO2020097258A5 (https=)
CN101420950A (zh) 杜兴肌营养不良的治疗
JPWO2023091606A5 (https=)